A Clinical Study to Evaluate the Efficacy and Safety of MIN-102 (IMP) in Male AMN Patients.
Clinical trial NCT03231878 · COMPLETED
Trial details
- NCT number
- NCT03231878
- Sponsor
- Minoryx Therapeutics, S.L.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-08
- Primary completion
- 2021-06-25
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.